For not just years but decades, Medtronic (NYSE: MDT) has proven to be a reliable dividend growth stock to own. Let's take a ...

Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.

Medtronic is picking up steam with recent product launches, and its balance sheet is a fortress. Read more about MDT stock ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Bernstein analyst Lee Hambright lowered the firm’s price target on Medtronic (MDT) to $93 from $97 and keeps an Outperform rating on the shares ...

Medtronic offers solid income potential with a 3.5% dividend yield. Read why MDT stock’s forward P/E ratio signals possible ...

Medtronic PLC closed $12.81 short of its 52-week high ($92.68), which the company reached on October 24th.

Piper Sandler analyst Matthew O’Brien reiterated a Hold rating on Medtronic (MDT – Research Report) today. The company’s shares opened today at ...

Across her two years as CIO of Medtronic, Rashmi Kumar has driven initiatives like hyper-automation, digital-first strategies ...

Kuros Biosciences USA's strategic, exclusive sales agency agreement with Medtronic could boost adoption of its MagnetOs bone ...

Endologix announced today that President and CEO Dr. Matt Thompson intends to step down and take on a new role.

On Monday, Medtronic PLC (MDT) stock saw a decline, ending the day at $79.84 which represents a decrease of $-1.11 or -1.37% from the prior close of $80.95. The stock opened at $80.52 and touched a ...